Icines Pharmaceuticals Private Limited
About Icines Pharmaceuticals Private Limited
Data last updated:
Icines Pharmaceuticals Private Limited is a private limited company based in Saharanpur, Uttar Pradesh, India. It operates in the repair services segment of the electronics sector. It was incorporated on 27 July 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U52609UP2018PTC106577. Its GSTIN is 09AAECI9468H1Z0 (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹4 Lakh. It is led by directors Anil Gagneja and Manisha Gagneja.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Saharanpur, Uttar Pradesh.
As per the financials filed for FY 2024, the company reported a revenue of ₹15.34 Lakh, a growth of 40% compared to the previous year. For the same year it recorded a net loss of ₹5.82 Lakh (net margin -38%) and EBITDA of -₹4.41 Lakh (EBITDA margin -28.7%). Revenue has grown at a compounded annual rate (CAGR) of 104% over three years.
Company details
Contact details
Icines Pharmaceuticals Private Limited's registered office is in Saharanpur, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressShop No 181, Transport Nagar Yojna Dara Rajpura Dehradun Road, Saharanpur, Uttar Pradesh, India – 247001
- IndustryElectrnoics, Repair Services
To see the full contact details of Icines Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Icines Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Icines Pharmaceuticals Private Limited, buy the company report.
Financials of Icines Pharmaceuticals Private Limited
FY 2025 filings availableIcines Pharmaceuticals Private Limited reported revenue of ₹15.34 Lakh (up 40% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 104% over three years, including 40% growth in the latest year. EBITDA rose 48% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹4.41 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹5.82 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -28.7% | ||||
| Net Profit Margin | -38% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Icines Pharmaceuticals Private Limited, buy the company report.
Board of directors of Icines Pharmaceuticals Private Limited
Icines Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anil Gagneja | Director | 18 May 2023 | 3 Years 5 Months | Current |
| Manisha Gagneja | Director | 27 Jul 2018 | 8 Years 2 Months | Current |
Legal cases
No court or tribunal cases involving Icines Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Icines Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Icines Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAECI9468H1Z0 | Uttar Pradesh | Active | 29 Nov 2019 |
To see the full GST registrations and return filing status of Icines Pharmaceuticals Private Limited, buy the company report.
Recent activity
Icines Pharmaceuticals Private Limited has 3 board changes on record since 2018: 2 appointments and 1 cessation. The latest: Amar Nath Gagneja ceased to be Director on 18 May 2023.
Frequently asked questions
Icines Pharmaceuticals is an active private limited company based in Saharanpur, Uttar Pradesh, India. The company works in repair services, within the electronics industry. It was incorporated on 27 July 2018 (8+ years old) and is registered under CIN U52609UP2018PTC106577.
Icines Pharmaceuticals has 2 current directors:
- Anil Gagneja - Director
- Manisha Gagneja - Director
The latest financial statements of Icines Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Icines Pharmaceuticals is 09AAECI9468H1Z0, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Icines Pharmaceuticals is U52609UP2018PTC106577. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Icines Pharmaceuticals was incorporated on 27 July 2018, making it 8+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Amar Nath Gagneja ceased to be Director on 18 May 2023. Anil Gagneja was appointed as Director on 18 May 2023. Manisha Gagneja was appointed as Director on 27 Jul 2018.
The registered office of Icines Pharmaceuticals is at Shop No 181, Transport Nagar Yojna Dara Rajpura Dehradun Road, Saharanpur, Uttar Pradesh, India – 247001.
Icines Pharmaceuticals operates in the electronics industry, in the repair services segment.
Icines Pharmaceuticals can be reached at its registered office: Shop No 181, Transport Nagar Yojna Dara Rajpura Dehradun Road, Saharanpur, Uttar Pradesh, India – 247001.